ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,300,000 | +16.1% | 751,804 | 0.0% | 2.16% | -10.8% |
| Q2 2022 | $10,593,000 | -62.2% | 751,804 | -35.0% | 2.42% | -63.4% |
| Q1 2022 | $28,018,000 | +188.0% | 1,156,817 | +177.5% | 6.62% | +106.6% |
| Q4 2021 | $9,729,000 | +40.5% | 416,817 | 0.0% | 3.21% | +27.4% |
| Q3 2021 | $6,923,000 | -33.0% | 416,817 | -1.7% | 2.52% | -40.8% |
| Q2 2021 | $10,337,000 | -7.3% | 423,817 | -2.0% | 4.25% | -9.6% |
| Q1 2021 | $11,154,000 | -53.7% | 432,317 | -4.0% | 4.70% | -45.4% |
| Q4 2020 | $24,074,000 | -9.9% | 450,317 | -30.5% | 8.61% | -23.9% |
| Q3 2020 | $26,723,000 | -5.8% | 647,833 | +10.6% | 11.32% | -10.6% |
| Q2 2020 | $28,380,000 | +11.3% | 585,517 | -3.0% | 12.66% | -18.2% |
| Q1 2020 | $25,499,000 | +15.6% | 603,517 | +17.0% | 15.46% | +15.6% |
| Q4 2019 | $22,065,000 | – | 515,788 | – | 13.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |